Accumulus Technologies

Accumulus Technologies is a leading cloud technology provider reimagining how life sciences organizations and national regulatory authorities work together to accelerate the drug development lifecycle - from drug discovery through global availability. Spun out from nonprofit Accumulus Synergy in 2025, the company operates a secure, purpose-built, SaaS platform that enables real-time collaboration and continuous data streaming - powering faster decisions, global alignment, and accelerated access to therapies for patients worldwide.

The Accumulus platform connects life sciences organizations and regulators across more than 60 countries, supporting modern regulatory approaches such as reliance, work sharing, and simultaneous global submissions. Customers using the platform have achieved transformative results, including accelerating global approvals by up to 90%, realizing $10M+ in cost benefits, and improving operational efficiency by as much as 75%. The company is working to turn its vision into reality: where patients around the globe receive safe and effective medicines faster, where the same life-changing therapies become available to all citizens at the same time regardless of geography, and where collaborations like the development of COVID-19 vaccines become the norm rather than the exception.